Autopsy report · NCT02845050

Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“No participants found”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1, Phase 2
Sponsor: Ligartis GmbH
Sponsor type: Industry
Conditions: Bladder Cancer
Interventions: Vinflunine; Cisplatin; Radical cystectomy
Participants: 0
Sites: 2
Countries: Germany

Trials that died the same way

Sevoflurane and Propofol for Botulinum Toxin Injection
“No participants enrolled” (82% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.